IP Library Granted Patent US 9,970,931
Granted Patent B2
US 9,970,931 · App. 15/332,679 · Granted May 15, 2018

Methods for isolating a target analyte from a heterogenous sample

Inventors: Sergey A. Dryga (Albuquerque, NM); Victor C. Esch (Albuquerque, NM); Lisa-Jo Ann Clarizia (Albuquerque, NM); Eddie W. Adams (Albuquerque, NM); Thearith H. Ung (Albuquerque, NM); Ravil A. Sitdikov (Albuquerque, NM)
Assignee: DNAE Group Holdings Limited
G01N33/54333C07K16/1203C07K16/1267C12N13/00C12Q1/24G01N1/34G01N33/569C07K2317/33
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,970,931
App. No.
15/332,679
Granted
May 15, 2018
Kind
B2
Abstract

The invention generally relates to methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.

Claims (20)

1. A method for isolating at least one pathogen from a heterogeneous sample, the method comprising:

obtaining a heterogeneous sample comprising at least one pathogen;

incubating the sample with a composition comprising a plurality of sets of magnetic particles specific to one or more pathogens, wherein members of a first set of magnetic particles are conjugated to a first class of capture moiety, and members of a second set of magnetic particles are conjugated to a second class of capture moiety; and

separating particle bound pathogen from other components in the sample;

wherein the first and second classes of capture moieties are selected from the group consisting of antibodies, lectins, bacteriophages, antimicrobial agents, and oligonucleotides; and

wherein the first and second classes are different.

2. The method of claim 1 , wherein each set of magnetic particles is present at a concentration designed for detection of a specific pathogen in said sample.

3. The method of claim 2 , wherein the first and second set of magnetic particles are provided at different concentrations.

4. The method of claim 1 , wherein the pathogen is selected from the group consisting of fungi, bacteria and a combination thereof.

5. The method of claim 4 , wherein the fungi comprises two or more species of fungi selected from the group consisting of the Candida genus, Aspergillus genus, and Cryptococcus genus.

6. The method of claim 4 , wherein the bacteria comprise one or species of bacteria selected from the group consisting of Staphylococcus genus, Enterobacteriaceae genus, Acinetobacter genus, Strenotrophomonas genus, Pseudomonas genus, Neisseria genus, Clostridium genus, and Enterococcus genus.

7. The method of claim 1 , wherein members of the first class are different.

8. The method of claim 1 , wherein members of the first class are the same.

9. The method of claim 1 , wherein members of the second class are different.

10. The method of claim 1 , wherein members of the second class are the same.

11. The method of claim 1 , further comprising identifying the pathogen.

12. The method of claim 1 , further comprising lysing the separated pathogen to release nucleic acid.

13. The method of claim 11 , further comprising conducting an assay on the nucleic acid to identify the pathogen.

14. The method of claim 13 , wherein the assay is selected from the group consisting of a sequencing reaction and a polymerase chain reaction.

15. The method of claim 13 , wherein the assay is a multiplex assay.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2017
From: DRYGA, SERGEY A.; ESCH, VICTOR C.; CLARIZIA, LISA-JO ANN; ADAMS, EDDIE W.; UNG, THEARITH H.; SITDIKOV, RAVIL A.
To: NANOMR INC.
Reel/Frame 042178/0971 →
MERGER Recorded Apr 28, 2017
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 042179/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2017
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 042372/0001 →
CHANGE OF NAME Recorded Apr 28, 2017
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 042372/0037 →
Continuity (5)
Division 13952130 · Jul 26, 2013
Continuation In Part 13091510 · Apr 21, 2011
Provisional Application 61739616 · Dec 19, 2012
Provisional Application 61326588 · Apr 21, 2010
Related Publication 20170038374A1 · Feb 9, 2017